Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative pharmacokinetic study of Betaserc 24 mg versus Mertigo 12 mg under fasting conditions
TCTR20250302013Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of betahistine in vertigo (2 arms), sponsored by Bio-innova. Primary endpoint: Blood betahistine concentration-time profile. Status: unknown.
02
Drugs
betahistine
03
Conditions
vertigo
Beyond the preview
Go deeper on TCTR20250302013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250302013.